Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women.

PubWeight™: 2.07‹?› | Rank: Top 2%

🔗 View Article (PMC 2856618)

Published in Menopause on July 09, 2009

Authors

Alison J Huang1, George F Sawaya, Eric Vittinghoff, Feng Lin, Deborah Grady

Author Affiliations

1: Departments of Medicine, University of California, San Francisco, CA 94115, USA. ahuang@ucsfmed.org

Articles citing this

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA (2013) 7.19

Hot flashes and cardiac vagal control: a link to cardiovascular risk? Menopause (2010) 2.02

Hot flashes and carotid intima media thickness among midlife women. Menopause (2011) 1.99

Hot flashes and cardiac vagal control during women's daily lives. Menopause (2012) 1.78

Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause (2011) 1.72

History of hot flashes and aortic calcification among postmenopausal women. Menopause (2010) 1.63

Vasomotor symptoms and insulin resistance in the study of women's health across the nation. J Clin Endocrinol Metab (2012) 1.13

Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation. Menopause (2011) 1.07

Vasomotor symptoms and lipid profiles in women transitioning through menopause. Obstet Gynecol (2012) 1.00

Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation. Obstet Gynecol Clin North Am (2011) 0.91

Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors. J Clin Oncol (2012) 0.87

Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83

The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk. Menopause (2009) 0.82

Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE). Menopause (2016) 0.77

Hot Flash Frequency and Blood Pressure: Data from the Study of Women's Health Across the Nation. J Womens Health (Larchmt) (2016) 0.75

Reproductive endocrinology: menopausal vasomotor symptoms and insulin resistance. Nat Rev Endocrinol (2012) 0.75

Menopausal Hot Flashes and Carotid Intima Media Thickness Among Midlife Women. Stroke (2016) 0.75

Articles cited by this

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA (1998) 24.54

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91

Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health (2006) 4.51

Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med (2002) 3.68

National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med (2005) 2.57

Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation (2008) 2.33

Hot flushes. Lancet (2002) 2.28

Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10

Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med (2005) 1.86

Menopausal complaints are associated with cardiovascular risk factors. Hypertension (2008) 1.58

Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol (2002) 1.57

Is this woman perimenopausal? JAMA (2003) 1.31

Persistent hot flushes in older postmenopausal women. Arch Intern Med (2008) 1.28

Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol (2005) 1.25

Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med (2006) 1.25

Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy. Eur Heart J (2005) 1.16

Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease. Eur Heart J (2004) 1.14

Cutaneous and hemodynamic responses during hot flashes in symptomatic postmenopausal women. Menopause (2008) 1.10

Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause (2007) 1.06

Effects of symptomatic status and the menstrual cycle on hot flash-related thermoregulatory parameters. Menopause (2005) 1.03

Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol (2000) 0.95

[Influence of the presence of hot flashes during menopause on the metabolism of nitric oxide. Effects of hormonal replacement treatment]. Med Clin (Barc) (2000) 0.81

Articles by these authors

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One (2010) 10.39

Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med (2006) 6.14

Racial differences in incident heart failure among young adults. N Engl J Med (2009) 5.60

Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med (2009) 5.58

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med (2002) 5.42

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38

Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA (2002) 5.07

Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr (2008) 5.05

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91

Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28

Posttraumatic stress disorder and risk of dementia among US veterans. Arch Gen Psychiatry (2010) 4.27

Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol (2004) 4.03

Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell (2004) 4.00

The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med (2006) 3.93

Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med (2006) 3.71

Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA (2008) 3.62

Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med (2005) 3.56

Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr (2005) 3.54

Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39

Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san francisco men who have sex with men. J Urban Health (2005) 3.33

Support from hospital to home for elders: a randomized trial. Ann Intern Med (2014) 3.21

Recommendations for intrauterine contraception: a randomized trial of the effects of patients' race/ethnicity and socioeconomic status. Am J Obstet Gynecol (2010) 3.18

Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab (2006) 3.15

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13

Modelling clustered survival data from multicentre clinical trials. Stat Med (2004) 3.02

Food insecurity is associated with diabetes mellitus: results from the National Health Examination and Nutrition Examination Survey (NHANES) 1999-2002. J Gen Intern Med (2007) 3.01

Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med (2011) 3.00

What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One (2012) 2.97

Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol (2006) 2.94

Fetuin-A and incident diabetes mellitus in older persons. JAMA (2008) 2.92

Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA (2002) 2.91

Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood (2008) 2.91

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. Lancet Oncol (2007) 2.90

Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg (2009) 2.89

Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86

The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med (2004) 2.86

An HMM approach to genome-wide identification of differential histone modification sites from ChIP-seq data. Bioinformatics (2008) 2.85

Effect of awareness of language law on language access in the health care setting. J Gen Intern Med (2006) 2.82

High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr (2015) 2.80

Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA (2002) 2.73

Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2002) 2.69

A signal-noise model for significance analysis of ChIP-seq with negative control. Bioinformatics (2010) 2.66

The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol (2006) 2.64

Sexual activity and function in middle-aged and older women. Obstet Gynecol (2006) 2.59

A randomized comparison of total or supracervical hysterectomy: surgical complications and clinical outcomes. Obstet Gynecol (2003) 2.57

A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med (2012) 2.54

Weight loss: a novel and effective treatment for urinary incontinence. J Urol (2005) 2.52

Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med (2008) 2.49

Diagnostic tests: another frontier for less is more: or why talking to your patient is a safe and effective method of reassurance. Arch Intern Med (2010) 2.49

Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48

Pelvic organ prolapse surgery in the United States, 1997. Am J Obstet Gynecol (2002) 2.43

Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41

Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol (2002) 2.41

Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care (2007) 2.39

Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr (2004) 2.39

Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery. JAMA Intern Med (2013) 2.38

Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Ann Intern Med (2010) 2.37

Decay-accelerating factor modulates induction of T cell immunity. J Exp Med (2005) 2.34

Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res (2012) 2.34

Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS (2002) 2.33

Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model. Cancer (2014) 2.26

Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24

Comanagement of surgical patients between neurosurgeons and hospitalists. Arch Intern Med (2010) 2.22

Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis (2004) 2.21

Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial. J Gen Intern Med (2014) 2.20

Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med (2003) 2.20

Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol (2003) 2.19

Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned. Circulation (2002) 2.18

Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.18

Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst (2009) 2.17

Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med (2010) 2.14

Impact of proactive rounding by a rapid response team on patient outcomes at an academic medical center. J Hosp Med (2012) 2.12

Statin use and postoperative atrial fibrillation after major noncardiac surgery. Heart Rhythm (2011) 2.11

Association between marijuana exposure and pulmonary function over 20 years. JAMA (2012) 2.09

Association of major and minor ECG abnormalities with coronary heart disease events. JAMA (2012) 2.07

Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study. Arch Surg (2011) 2.05

Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA (2011) 2.04

Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02

Impact of decreased heparin dose for flush-lock of implanted venous access ports in pediatric oncology patients. Pediatr Blood Cancer (2014) 2.00

Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA (2004) 1.97

Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol (2005) 1.94